Leo Pharma

Type: Company
Name: Leo Pharma
Web Address: http://www.leo.se
First reported Oct 21 2014 - Updated Oct 21 2014 - 1 reports

ω-3FA supplements potentially useful for lipid level management during isotretinoin therapy

Among patients undergoing isotretinoin treatment for acne, researchers have found ω-3 fatty acid supplements may be a useful addition for the management of lipid levels.The researchers obtained data for 39 patients with acne who were treated with isotretinoin ... [Published Orthopedics Today - Oct 21 2014]
First reported Oct 20 2014 - Updated Oct 20 2014 - 1 reports

Keratinocyte cancer imposes heavy burden on Dutch population

Researchers found keratinocyte cancer has become a large burden in Dutch society, and because incidence rates continue to rise, management has become even more challenging.Data for all patients with newly diagnosed keratinocyte cancer were obtained from ... [Published Orthopedics Today - Oct 20 2014]
First reported Oct 09 2014 - Updated Oct 09 2014 - 1 reports

High Court finds psoriasis treatment patent invalid

The High Court has found that a patent for an ointment used to treat psoriasis was invalid for obviousness. ( Teva UK Ltd and another v Leo Pharma AS and another [2014] EWHC 3096 (Pat), 6 October 2 ... [Published Practical Law Company - Oct 09 2014]
First reported Oct 09 2014 - Updated Oct 09 2014 - 1 reports

LEO Pharma Inc. Announced New Taclonex® calcipotriene and betamethasone dipropionate Topical Suspension, 0.005%/0.064% Indication for Treatment of...

LEO Pharma Inc. Announced New Taclonex calcipotriene and betamethasone dipropionate Topical Suspension, 0.005%/0.064% Indication for Treatment of Scalp Plaque Psoriasis in Pediatric Patients Ages 12-17By a News Reporter-Staff News Editor at Health & Medicine ... [Published Pharmacy Choice - Oct 09 2014]
First reported Sep 30 2014 - Updated Sep 30 2014 - 2 reports

LEO Pharma Inc. Announced New Taclonex® (calcipotriene and betamethasone dipropionate) Topical Suspension, 0.005%/0.064% Indication for Treatment of Scalp Plaque Psoriasis in Pediatric Patients Ages 12-17

PARSIPPANY, N.J.--(EON: Enhanced Online News)--LEO Pharma Inc., a wholly owned U.S. subsidiary of LEO Pharma A/S, today announced a new Taclonex® (calcipotriene and betamethasone dipropionate) Topical Suspension indication for a topical combination treatment ... [Published EON Consumer - Sep 30 2014]
First reported Sep 19 2014 - Updated Sep 19 2014 - 1 reports

EyeForPharma Multichannel Marketing Summit 2014: "Your desk is the worst place from which to view the world"

One of the key messages from the EyeForPharma Multichannel Marketing Summit in London yesterday was that pharma has to look outside the industry itself and down the supply chain to prescribing clinicians and patients in order to have truly meaningful ... [Published Pharma Letter - Sep 19 2014]
First reported Sep 19 2014 - Updated Sep 19 2014 - 2 reports

Spain's pharma community has made necessary adjustments in recession, says PharmaBoardroom report

The Spanish pharma community has remained pragmatic throughout the European recession, says PharmaBoardroom’s Healthcare and Life Sciences Review on Spain.It highlights the fact that the Spanish pharma industry had been growing at an unsustainable rate, ... [Published Pharma Letter - Sep 19 2014]
First reported Sep 17 2014 - Updated Sep 17 2014 - 1 reports

Psoriasis and Psoriatic Arthritis Patient Care: What Pharmacists Should Know

This activity is supported by educational grants from AbbVie Inc and LEO Pharma Inc.Ryan Nolan, PharmD, MBA, CSPManager, Clinical ServicesDiplomat Specialty PharmacyFlint, MichiganGary Rice, RPh, MS, MBA, CSPVice President of Clinical ServicesDiplomat ... [Published Pharmacy Times - Sep 17 2014]
First reported Sep 16 2014 - Updated Sep 16 2014 - 1 reports

Royals part of trade delegation heading to Canada

The Crown Prince Couple has teamed up with the trade and development minister, Mogens Jensen, as part of a Danish delegation heading to Canada to boost trade between the nations.The delegation also includes about 80 Danish companies that are looking to ... [Published Copenhagen Post - Sep 16 2014]
First reported Sep 08 2014 - Updated Sep 08 2014 - 1 reports

Peril, Not Progress on Transatlantic Trade Deal

Only a year ago, hopes were high of rapid progress towards a transatlantic trade deal that would boost the European and USeconomies—and ease conditions for drug firms on both sides of the ocean. TTIP, the Transatlantic Trade and Investment Partnershi ... [Published Pharmaceutical Executive - Sep 08 2014]
First reported Aug 12 2014 - Updated Aug 12 2014 - 2 reports

TACLONEX (Calcipotriene And Betamethasone Dipropionate) Ointment [LEO Pharma Inc.]

First reported Jul 15 2014 - Updated Jul 16 2014 - 1 reports

LEO Pharma & KLOX Technologies strike global dermatology deal

Dermatology leader LEO Pharma expands into acne, further pushing the boundaries of dermatology careKLOX gains access to global market, cementing its position as a leading Canadian life sciences specialty companyBALLERUP, Denmark and LAVAL, QC, July 15, ... [Published PR Newswire: Financial Services - Jul 15 2014]

Quotes

"At LEO, our goal is to help people achieve healthy skin," said Jorgen Damsbo Andersen, chief executive officer of LEO Pharma Inc. "With this new indication, we're able to help younger people with scalp plaque psoriasis who until now have not had access to Taclonex Topical Suspension."
"To our knowledge, this network meta-analysis is the largest review, including nearly 45,000 patients, assessing the clinical outcomes and safety associated with different anticoagulation strategies for the treatment of acute [VTE]" lead author Lana Castellucci, MD, stated in a university news release. Dr...
EyeForPharma Multichannel Marketing Summit 2014: "Your desk is the worst place from which to view the world"
Juan López-Belmonte, chief executive of Laboratorios Rovi, said: "Spain was living in a bubble-like dream in many ways, above what the country and its economic capabilities could deliver.”"

More Content

All (27) | News (19) | Reports (0) | Blogs (7) | Audio/Video (0) | Fact Sheets (0) | Press Releases (1)
sort by: Date | Relevance
ω-3FA supplements potentially useful for lipid ... [Published Orthopedics Today - Oct 21 2014]
Keratinocyte cancer imposes heavy burden on Dut... [Published Orthopedics Today - Oct 20 2014]
High Court finds psoriasis treatment patent inv... [Published Practical Law Company - Oct 09 2014]
LEO Pharma Inc. Announced New Taclonex® calcip... [Published Pharmacy Choice - Oct 09 2014]
Dermira IPO: Less Appealing In A Hot IPO Week [Published Seeking Alpha - Oct 02 2014]
LEO Pharma Inc. Announced New Taclonex® (calcip... [Published EON Consumer - Sep 30 2014]
LEO Pharma Inc. Announced New Taclonex® (calcip... [Published Business Wire Health News - Sep 30 2014]
VTE Treatments Similarly Safe, Effective, but N... [Published American Journal of Public Health - Sep 24 2014]
EyeForPharma Multichannel Marketing Summit 2014... [Published Pharma Letter - Sep 19 2014]
Spain's pharma community has made necessary adj... [Published Pharma Letter - Sep 19 2014]
Antares Pharma Announces Promotion of Robert F.... [Published FierceBiotech - Sep 19 2014]
PharmaBoardroom Releases New Spain Pharmaceutic... [Published Minyanville - Sep 19 2014]
Psoriasis and Psoriatic Arthritis Patient Care:... [Published Pharmacy Times - Sep 17 2014]
Royals part of trade delegation heading to Canada [Published Copenhagen Post - Sep 16 2014]
Antares Pharma Announces Promotion of Robert F.... [Published Crawford Financial Planning - Sep 15 2014]
Peril, Not Progress on Transatlantic Trade Deal [Published Pharmaceutical Executive - Sep 08 2014]
TTIP: From Hot Tip to Oblivion? [Published Pharmaceutical Executive - Aug 18 2014]
TACLONEX (Calcipotriene And Betamethasone Dipro... [Published DailyMed Drug Label Updates for the last seven ... - Aug 12 2014]
TACLONEX (Calcipotriene And Betamethasone Dipro... [Published DailyMed Drug Label Updates for the last seven ... - Aug 12 2014]
LEO Pharma & KLOX Technologies strike global de... [Published PR Newswire: Financial Services - Jul 15 2014]
LEO Pharma & KLOX Technologies strike global de... [Published Financial Services - Jul 15 2014]
Dovobet ointment approved to treat psoriasis vu... [Published PBR - News - Jul 07 2014]
Antares Pharma Reports First Quarter 2014 Opera... [Published Business Wire Health News - May 09 2014]
Stop Paying Lip Service to Patient-Centricity [Published Pharmaceutical Executive - Apr 10 2014]
Perrigo launches generic Taclonex ointment to t... [Published PharmaBiz - Apr 03 2014]
MobMe Gets A Shot in The Arm With Rs.16 Cr Ange... [Published Silicon India - Mar 03 2014]
Actinic Solar Keratosis Global Clinical Trials ... [Published BioPortfolio - Feb 20 2014]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
LEO Pharma Inc. Announced New Taclonex® (calcip... [Published EON Consumer - Sep 30 2014]
PARSIPPANY, N.J.--(EON: Enhanced Online News)--LEO Pharma Inc., a wholly owned U.S. subsidiary of LEO Pharma A/S, today announced a new Taclonex® (calcipotriene and betamethasone dipropionate) Topical Suspension indication for a topical combination treatment ...
LEO Pharma Inc. Announced New Taclonex® (calcip... [Published Business Wire Health News - Sep 30 2014]
PARSIPPANY, N.J.--(BUSINESS WIRE)--LEO Pharma Inc., a wholly owned U.S. subsidiary of LEO Pharma A/S, today announced a new Taclonex® (calcipotriene and betamethasone dipropionate) Topical Suspension indication for a topical combination treatment of plaque ...
TACLONEX (Calcipotriene And Betamethasone Dipro... [Published DailyMed Drug Label Updates for the last seven ... - Aug 12 2014]
Updated Date: Aug 11, 2014 EST ...
TACLONEX (Calcipotriene And Betamethasone Dipro... [Published DailyMed Drug Label Updates for the last seven ... - Aug 12 2014]
Updated Date: Aug 11, 2014 EST ...
LEO Pharma & KLOX Technologies strike global de... [Published PR Newswire: Financial Services - Jul 15 2014]
Dermatology leader LEO Pharma expands into acne, further pushing the boundaries of dermatology careKLOX gains access to global market, cementing its position as a leading Canadian life sciences specialty companyBALLERUP, Denmark and LAVAL, QC, July 15, ...
1 2

Press Releases

sort by: Date | Relevance
LEO Pharma & KLOX Technologies strike global de... [Published Financial Services - Jul 15 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.